Prostate Cancer
Page 1 • 2 itemsGlobal prostate cancer market intelligence for pharma BD, investors & analysts. Track drug development, clinical trials, and regulatory approvals.
FDA Advisory Committee Recommends AstraZeneca's TRUQAP for PTEN-Deficient Prostate Cancer
FDA Advisory Committee votes 7-1 to recommend AstraZeneca's TRUQAP (capivasertib) for PTEN-deficient metastatic hormone-sensitive prostate cancer patients.
Francis Medical's Vanquish System Performs First Commercial Prostate Ablation Procedure in Midwest
Francis Medical's FDA-cleared Vanquish Water Vapor Ablation System completes first commercial prostate tissue ablation procedure in Midwest region.